Therapie der intraabdominellen pilzinfektionen

Translated title of the contribution: Therapy of intraabdominal fungal infections

Peter Kujath*, R. Bouchard, J. Nolde, J. Scheele

*Corresponding author for this work
1 Citation (Scopus)


Candida albicans is the fourth most germ that can be identified on surgical intensive care unit (SICU). During the course of severe peritonitis recognition of Candida is crucial for physicians but interpretation of Candida-positive microbiologic samples is difficult. The indication for antimycotic therapy requires differentiation between harmless contamination or severe invasive mycosis associated with high mortality. Therefore, we propose a four-stage classification. Stage I is the initial contamination of the abdominal cavity by Candida spp. Stage IIa is characterized by persistence of fungi in patients without risk factors, lib with risk factors respectively. Stage III means histological evidence of Candida invasion into the peritoneal layer. Stage IV is a generalized infection with fungemia/fungal sepsis. We recommend antimycotic therapy in stage lib or higher.

Translated title of the contributionTherapy of intraabdominal fungal infections
Original languageGerman
JournalMycoses, Supplement
Issue number1
Pages (from-to)61-65
Number of pages5
Publication statusPublished - 2005

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)


Dive into the research topics of 'Therapy of intraabdominal fungal infections'. Together they form a unique fingerprint.

Cite this